Head and Neck Diseases by Alexandros G.Sfakianakis: Safety of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials

Παρασκευή 6 Ιουλίου 2018

Safety of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials

British Journal of Dermatology, EarlyView.

https://ift.tt/2lZCGny

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου